Skandinaviska Enskilda Banken Ab (Publ) Gilead Sciences, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$22.4 Billion
Q2 2025

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 2,352,958 shares of GILD stock, worth $283 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

2,352,958

Previous 2,100,850 12.0%

Holding current value

$283 Million

Previous $235 Million 10.82%

% of portfolio

1.16%

Previous 1.18%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$96.91 - $113.0 $24.4 Million - $28.5 Million	252,108 Added 12.0%	2,352,958 $261 Million
Q1 2025 May 07, 2025	BUY	$89.14 - $117.41 $25.2 Million - $33.2 Million	282,970 Added 15.57%	2,100,850 $235 Million
Q4 2024 Feb 10, 2025	BUY	$83.95 - $97.9 $91.2 Million - $106 Million	1,085,987 Added 148.38%	1,817,880 $168 Million
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $9.74 Million - $12.3 Million	146,309 Added 24.99%	731,893 $61.3 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $32.4 Million - $37.4 Million	-512,849 Reduced 46.69%	585,584 $40.2 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $38 Million - $46.4 Million	-531,450 Reduced 32.61%	1,098,433 $80.5 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $5.6 Million - $6.35 Million	-76,458 Reduced 4.48%	1,629,883 $132 Million
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $7.12 Million - $7.77 Million	96,281 Added 5.98%	1,706,341 $128 Million
Q2 2023 Aug 07, 2023	SELL	$76.01 - $86.7 $4.6 Million - $5.24 Million	-60,485 Reduced 3.62%	1,610,060 $124 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $5.78 Million - $6.59 Million	74,764 Added 4.69%	1,670,545 $139 Million
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $5.4 Million - $7.75 Million	86,629 Added 5.74%	1,595,781 $137 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $4.59 Million - $5.25 Million	-77,169 Reduced 4.86%	1,509,152 $93.1 Million
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $6.17 Million - $6.95 Million	106,913 Added 7.23%	1,586,321 $98.1 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $38.6 Million - $48.4 Million	-666,453 Reduced 31.06%	1,479,408 $88 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $16.1 Million - $18.3 Million	248,016 Added 13.07%	2,145,861 $157 Million
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $11.9 Million - $12.8 Million	175,606 Added 10.2%	1,897,845 $133 Million
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $8.45 Million - $9.23 Million	-133,110 Reduced 7.17%	1,722,239 $119 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $17.4 Million - $19.9 Million	290,525 Added 18.57%	1,855,349 $120 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $13.2 Million - $15.1 Million	-233,205 Reduced 12.97%	1,564,824 $91.2 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $4.31 Million - $5.41 Million	69,336 Added 4.01%	1,798,029 $114 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $19 Million - $22 Million	-262,288 Reduced 13.17%	1,728,693 $133 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $71.6 Million - $91.7 Million	-1,143,699 Reduced 36.49%	1,990,981 $149 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $11.8 Million - $13 Million	-191,790 Reduced 5.77%	3,134,680 $204 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $83.5 Million - $92.1 Million	-1,335,120 Reduced 28.64%	3,326,470 $211 Million
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $22.9 Million - $25.7 Million	370,724 Added 8.64%	4,661,590 $315 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $35 Million - $39.3 Million	-560,341 Reduced 11.55%	4,290,866 $279 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $51.7 Million - $67.4 Million	853,183 Added 21.34%	4,851,207 $303 Million
Q3 2018 Nov 05, 2018	BUY	$71.28 - $78.92 $211 Million - $234 Million	2,959,697 Added 285.04%	3,998,024 $309 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $6.23 Million - $7.27 Million	96,065 Added 10.2%	1,038,327 $73.6 Million
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $265 Million - $323 Million	-3,634,807 Reduced 79.41%	942,262 $71 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $24.9 Million - $29.3 Million	-350,516 Reduced 7.11%	4,577,069 $328 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $248 Million - $294 Million	3,434,450 Added 230.02%	4,927,585 $399 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,493,135	1,493,135 $0

Others Institutions Holding GILD

# of Institutions

2,340

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $151B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Gilead Sciences, Inc. Transaction History